Bridgeway Capital Management, LLC Eli Lilly & CO Transaction History

Bridgeway Capital Management, LLC

$4.44 Billion
Q3 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 33,087 shares of LLY stock, worth $26 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

33,087

Previous 29,470 12.27%

Holding current value

$26 Million

Previous $26.7 Million 9.86%

% of portfolio

0.66%

Previous 0.64%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $2.79 Million - $3.47 Million	3,617 Added 12.27%	33,087 $29.3 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $1.82 Million - $2.28 Million	-2,506 Reduced 7.84%	29,470 $26.7 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $20,727 - $27,729	35 Added 0.11%	31,976 $24.9 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $191,694 - $225,982	365 Added 1.16%	31,941 $18.6 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $195,615 - $269,685	-450 Reduced 1.41%	31,576 $17 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $8.38 Million - $11.2 Million	23,884 Added 293.34%	32,026 $15 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $1.7 Million - $1.99 Million	-5,462 Reduced 40.15%	8,142 $2.8 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $1.78 Million - $2.08 Million	-5,546 Reduced 28.96%	13,604 $4.98 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $3.79 Million - $4.32 Million	-12,800 Reduced 40.06%	19,150 $6.19 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $1.06 Million - $1.24 Million	-3,800 Reduced 10.63%	31,950 $10.4 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $10.6 Million - $13.2 Million	-45,325 Reduced 55.91%	35,750 $10.2 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $13.6 Million - $16.9 Million	60,425 Added 292.62%	81,075 $22.4 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $4.58 Million - $5.63 Million	20,650 New	20,650 $4.77 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $297,625 - $368,375	-2,500 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $52.6 Million - $57.2 Million	-492,650 Reduced 99.5%	2,500 $280,000
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $3.91 Million - $4.56 Million	-35,300 Reduced 6.65%	495,150 $54.9 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $1 Million - $1.18 Million	9,000 Added 1.73%	530,450 $68.8 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $55.2 Million - $61.9 Million	521,450 New	521,450 $60.3 Million

Others Institutions Holding LLY

# of Institutions

3,994

Shares Held

752M

Call Options Held

7.31M

Put Options Held

9.23M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $747B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Eli Lilly & CO Transaction History